Capital Research Global Investors Conmed Corp Transaction History
Capital Research Global Investors
- $443 Billion
- Q2 2024
A detailed history of Capital Research Global Investors transactions in Conmed Corp stock. As of the latest transaction made, Capital Research Global Investors holds 1,709,441 shares of CNMD stock, worth $128 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,709,441
Previous 1,460,794
17.02%
Holding current value
$128 Million
Previous $117 Million
1.3%
% of portfolio
0.03%
Previous 0.03%
Shares
27 transactions
Others Institutions Holding CNMD
# of Institutions
307Shares Held
35.5MCall Options Held
44.6KPut Options Held
114K-
Black Rock Inc. New York, NY4.99MShares$373 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$261 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.82MShares$211 Million0.95% of portfolio
-
Bank Of America Corp Charlotte, NC1.32MShares$98.9 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.29MShares$96.1 Million0.56% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.28B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...